The purpose of this study is to test apremilast and compare its effects to placebo. The study will also test etanercept, a drug approved to treat psoriasis, and compare its effects to placebo.
Adults 18 years old and older who have been diagnosed with psoriasis.
Participants will have a physical examination, physician assessments, and will be asked to complete questionnaires. Urine and blood samples will also be taken. Participants will receive a weekly injection and a pill to be taken twice a day for the first 16 weeks of the study. During this time, participants may receive a placebo pill, a placebo injection, or both. After that, participants will only receive a pill (active medication) to be taken during the rest of the study.
The study lasts for a period of up to 112 weeks or approximately 2 years.
Please contact Lori Miedwig, CCRP, at (217) 545-4402 or email email@example.com
Stephen Stone, MD